📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Cefepime/sulbactam as an enhanced antimicrobial combination therapy for the treatment of MDR Gram-negative infections. (2020)

First Author: Wareham DW

Attributed to: Mathematical and Statistical Modelling to Optimise Paediatric Medicines Research funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/jac/dkz420

PubMed Identifier: 31617905

Publication URI: http://europepmc.org/abstract/MED/31617905

Type: Journal Article/Review

Volume: 75

Parent Publication: The Journal of antimicrobial chemotherapy

Issue: 1

ISSN: 0305-7453